<Anchor>

33 new corona19 confirmed patients were announced yesterday (14th), and only 14 local occurrences. For the time being, we will have no choice but to reduce the spread. The government plans to focus on drug development and antibody research, considering that Corona 19 is prolonged.

Reporter Kwak Sang is on the sidewalk.

<Reporter>

Of the 33 corona19 newly confirmed cases, 14 cases, excluding 19 foreign inflows, are domestic cases.

Seven in Seoul and four in Gyeonggi, 11 in the metropolitan area, and two and one in Jeonbuk and Chungbuk respectively.

As small-scale infections in the metropolitan area are not persistent, health authorities are facing the challenge of simultaneously blocking domestic outbreaks and influx.

[Kwon Joon-wook/National Health Research Institute: Expression to end the epidemic is only an expectation. There is only a way to keep the fashion scale down and manage it through distance, wearing a mask and personal hygiene… .]

Corona 19 The most urgent thing in terms of prolongation is the development of therapeutics and continuous research.

Remedyvir, a treatment, has been administered to 49 seriously ill patients being treated at 24 hospitals in Korea, and the clinical trial of a blood clotting agent made by concentrating the plasma of cured patients is expected to begin as early as September.

In the UK's King's College study, studies were conducted in Korea as well, indicating that only 17% of patients had strong antibody responses until three months later.

Health officials say they plan to get the blood of a cured person on a monthly basis and study how long the antibody will last.